Cibc Private Wealth Group, LLC Novavax Inc Transaction History
Cibc Private Wealth Group, LLC
- $51.4 Billion
- Q2 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Novavax Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 2,308 shares of NVAX stock, worth $21,187. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,308
Previous 308
649.35%
Holding current value
$21,187
Previous $1,000
2800.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NVAX
# of Institutions
286Shares Held
84.7MCall Options Held
5.38MPut Options Held
8.62M-
Vanguard Group Inc Valley Forge, PA14.1MShares$129 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$109 Million0.0% of portfolio
-
Shah Capital Management9.82MShares$90.1 Million40.63% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY6.32MShares$58 Million0.08% of portfolio
-
State Street Corp Boston, MA6.07MShares$55.7 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $718M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...